Therefore, given the paucity of evidence supporting that SGLT2 inhibitors induce shortening of the cardiac APD in response to pathological stimuli other than hyperglycemia, we investigated whether EMPA affects APD in rat and human iPSCs-derived cardiomyocytes subjected to chemical hypoxia. Here, SLC5A2 is linked to Hyperglycemia.